BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12169394)

  • 1. Expression of membrane type I-matrix metalloproteinase in oral squamous cell carcinoma.
    Myoung H; Kim MJ; Hong SD; Lee JI; Lim CY; Hong SP
    Cancer Lett; 2002 Nov; 185(2):201-9. PubMed ID: 12169394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
    Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
    Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis.
    de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF
    J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis.
    Pu Y; Wang L; Wu H; Feng Z; Wang Y; Guo C
    Oncol Rep; 2014 Jun; 31(6):2644-50. PubMed ID: 24700287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
    Erdem NF; Carlson ER; Gerard DA; Ichiki AT
    J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
    Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.
    Katayama A; Bandoh N; Kishibe K; Takahara M; Ogino T; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2004 Jan; 10(2):634-40. PubMed ID: 14760086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key proteins of invadopodia are overexpressed in oral squamous cell carcinoma suggesting an important role of MT1-MMP in the tumoral progression.
    Mitre GP; Balbinot KM; Ribeiro ALR; da Silva Kataoka MS; de Melo Alves Júnior S; de Jesus Viana Pinheiro J
    Diagn Pathol; 2021 Apr; 16(1):33. PubMed ID: 33879222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.
    Zhai Y; Hotary KB; Nan B; Bosch FX; Muñoz N; Weiss SJ; Cho KR
    Cancer Res; 2005 Aug; 65(15):6543-50. PubMed ID: 16061633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of fibroblasts in MMP-2 binding and activation on the surface of oral squamous cell carcinoma cells.
    Hayashido Y; Urabe K; Yoshioka Y; Kitano H; Okamoto T; Matsuya T
    Int J Oncol; 2003 Mar; 22(3):657-62. PubMed ID: 12579321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
    Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
    Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
    Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
    Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complex.
    Li YY; Zhou CX; Gao Y
    Oral Oncol; 2015 Oct; 51(10):935-43. PubMed ID: 26194050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.
    Harada T; Arii S; Mise M; Imamura T; Higashitsuji H; Furutani M; Niwano M; Ishigami S; Fukumoto M; Seiki M; Sato H; Imamura M
    J Hepatol; 1998 Feb; 28(2):231-9. PubMed ID: 9514536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
    Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
    J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
    de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
    Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
    Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.
    Davidson B; Goldberg I; Kopolovic J; Lerner-Geva L; Gotlieb WH; Ben-Baruch G; Reich R
    Gynecol Oncol; 1999 Jun; 73(3):372-82. PubMed ID: 10366463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.